Prolactin and Growth Hormone in Health and Disease

  • William H. Daughaday
Part of the Contemporary Endocrinology book series (COE, volume 2)


The pituitary is best considered as five more or less independent endocrine secretory units that happen to be accommodated in the same anatomical location. Because the thyrotropin, corticotropin, and gonadotropin secretory units are more readily considered in relation to their end organ effects, this review focuses on the two secretory units for prolactin and growth hormone (GH) that act without an intermediary endocrine target gland. While prolactin exerts all of its physiologic effects directly, some of the physiologic actions of GH are mediated by the somatomedins (insulin-like growth factors). In this chapter the principal recent contribution to our knowledge of prolactin, GH, and somatomedins as it relates to human physiology and disease will be reviewed. Even with this restricted scope no attempt has been made to include all publications in this area, but those of greatest interest and application will be considered.


Growth Hormone Human Growth Hormone Growth Hormone Treatment Acromegalic Patient Serum Prolactin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cooke, N. E., Coit, D., Shine, J., Baxter, J. D., and Martial, J. A., 1981, Human prolactin: cDNA structural analysis and evolutionary comparisons, J. Biol. Chem. 256: 4007–4016.PubMedGoogle Scholar
  2. 2.
    Barsh, G. S., Seeburg, P. H., and Gelinas, R. E., 1983, The human growth hormone gene family: Structure and evolution of the chromosomal locus, Nucleic Acid Res. 11: 3939–3958.PubMedCrossRefGoogle Scholar
  3. 3.
    Nybert, F., Roos, P., and Wide, L., 1980, Human pituitary prolactin: Isolation and characterization of three isohormones with different bioassay and radioimmunoassay activities, Biochim. Biophys. Acta 625: 255–265.CrossRefGoogle Scholar
  4. 4.
    Gamier, P. E., Aubert, M. L., Kaplan, S. L., and Grumbach, M. M., 1978, Heterogeneity of pituitary and plasma prolactin in man: Decreased affinity of “big” prolactin in a radioreceptor assay and evidence for its secretion, J. Clin. Edocrinol. Metab. 47: 1273–1281.CrossRefGoogle Scholar
  5. 5.
    Kiefer, K. A., and Malarkey, W. B., 1978, Size heterogeneity of human prolactin in CSF and serum: Experimental conditions that alter gel filtration patterns, J. Clin. Endocrinol. Metab. 46: 119–124.PubMedCrossRefGoogle Scholar
  6. 6.
    Jordan, R. M., and Kendall, J. W., 1978, Dissociation of plasma and CSF prolactin heterogeneity, Acta Endocrinol. (Copenhagen) 89: 38–47.Google Scholar
  7. 7.
    Pochet, R., Martial, J., and Pasteels, J. L., 1982, Detection and characterization of human prolactin messenger RNA in chorion-decidua, DNA 1: 193.Google Scholar
  8. 8.
    Golander, A., Hurley, T., Barrett, j., Hizi, A., and Handwerger, S., 1978, Prolactin synthesis by human chorion-decidual tissue: A possible source of prolactin in the amniotic fluid, Science 202: 311–313.PubMedCrossRefGoogle Scholar
  9. 9.
    Maslar, I. A., and Riddick, D. H., 1979, Prolactin production by human endometrium during the normal menstrual cycle, Am. J. Obstet. Gynecol. 135: 751–754.PubMedGoogle Scholar
  10. 10.
    Riddick, D. H., and Maslar, I. A., 1981, The transport of prolactin by human fetal membranes, J. Clin. Endocrinol. Metab. 52: 220–224.PubMedCrossRefGoogle Scholar
  11. 11.
    McCoshen, J. A., Tagger, O. Y., Wodzicki, A., and Tyson, J. E., 1982, Choriodecidual adhesion promotes decidual prolactin transport by human fetal membrane, Am. J. Physiol. 243: 552–557.Google Scholar
  12. 12.
    Ylikorkala, O., Kivinen, S., and Reinila, M., 1979, Serial prolactin and thyrotropin responses to thyrotropin-releasing hormone throughout normal human pregnancy, J. Clin. Endocrinol. Metab. 48: 288–292.PubMedCrossRefGoogle Scholar
  13. 13.
    Kletzky, O. A., Marrs, R. P., Howard, W. F., McCormick, W., and Mishell, D. R., Jr., 1980, Prolactin synthesis and release during pregnancy and puerperium, Am. J. Obstet. Gynecol. 136: 545–550.PubMedGoogle Scholar
  14. 14.
    Ylikorkala, O., Huhtaniemi, I., Tuimala, R., and Seppala, M., 1979, Subnormal postconceptional levels of prolactin do not interfere with the early events of human pregnancy, Fertil. Steril. 32: 286–288.PubMedGoogle Scholar
  15. 15.
    Yuen, B. H., Cannon, W., Lewis, J., Sy, L., and Woolley, S., 1980, Possible role for prolactin in the control of human chorionic gonadotropin and estrogen secretion by the fetoplacental unit, Am. J. Obstet. Gynecol. 136: 286–291.Google Scholar
  16. 16.
    Perlman, M., Schenker, J., Glassman, M., and Ben-David, M., 1978, Prolonged hyperprolactinemia in preterm infants, J. Clin. Endocrinol. Metab. 47: 894–897.PubMedCrossRefGoogle Scholar
  17. 17.
    Polleri, A., Masturzo, P., Vignola, G., Barreca, T., and Gallamini, A., 1978, Sleep-wake differences in serum prolactin levels in children, J. Endocrinol. Invest. 1: 347–350.PubMedGoogle Scholar
  18. 18.
    Large, D. M., Anderson, D. C., and Laing, I., 1980, Twenty-four hour profiles of serum prolactin during male puberty with and without gynaecomastia, Clin. Endocrinol. 12: 293–302.CrossRefGoogle Scholar
  19. 19.
    Spitz, I. M., Zylber, E., Cohen, H., Almaliach, U., and Leroith, D., 1979, Impaired prolactin response to thyrotropin-releasing hormone in isolated gonadotropin deficiency and exaggerated response in primary testicular failure, J. Clin. Endocrinol. Metab. 48: 941–945.PubMedCrossRefGoogle Scholar
  20. 20.
    Turksoy, R. N., 1979, Dissociation of prolactin responsiveness to thyrotropin-releasing hormone and chlorpromazine in a female with Kallmann’s syndrome, Fertil Steril. 32: 228–229.PubMedGoogle Scholar
  21. 21.
    Suter, S. N., Kaplan, S. L., Aubert, M. L., and Grumbach, M. M., 1978, Plasma prolactin and thyrotropin and response to thyrotropin-releasing factor in children with primary and hypothalamic hypothyroidism, J. Clin. Endocrinol. Metab. 47: 1015–1020.PubMedCrossRefGoogle Scholar
  22. 22.
    Honbo, K. S., van Herle, J. J., and Kellett, K. A., 1978, Serum prolactin levels in untreated primary hypothyroidism, Am. J. Med. 64: 782–787.PubMedCrossRefGoogle Scholar
  23. 23.
    Contreras, P., Generini, G., Michelsen, H., Pumarino, H., and Campino, C., 1981, Hyperprolactinemia and galactorrhea-Spontaneous versus iatrogenic hypothyroidism, J. Clin. Endocrinol. Metab. 53: 1036–1039.PubMedCrossRefGoogle Scholar
  24. 24.
    Ben-David, M., and Schenker, J. G., 1983, Transient hyperprolactinemia: A correctable cause of idiopathic female infertility, J. Clin. Endocrinol. Metab. 57: 442–444.PubMedCrossRefGoogle Scholar
  25. 25.
    Tolis, G., Goltzman, D., Guyda, H., and Mountokalakis, T., 1980, Hormonal derangements in uremia, J. Endocrinol. Invest. 3: 83–97.PubMedGoogle Scholar
  26. 26.
    Lim, V. S., Lim, S. C., Kathpalia, S. C., and Frohman, L. A., 1979, Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: Reversal after transplantation, J. Clin. Endocrinol. Metab. 48: 101–107.PubMedCrossRefGoogle Scholar
  27. 27.
    Gomez, F., Delacueva, R., Wauters, J. P., and Lemarchandberaud, T., 1980, Endocrine abnormalities in patients undergoing long-term hemodialysisThe role of prolactin, Am. J. Med. 68: 522–530.PubMedCrossRefGoogle Scholar
  28. 28.
    Vermeulen, A., and Ando, S., 1978, Prolactin and adrenal androgen secretion, Clin. Endocrinol. 8: 295–304.CrossRefGoogle Scholar
  29. 29.
    Parker, L. N., Chang, S., and Odell, W. D., 1978, Adrenal androgens in patients with chronic marked elevation of prolactin, Clin. Endocrinol. 8: 1–6.CrossRefGoogle Scholar
  30. 30.
    Lobo, R. A., Kletzky, O. A., Kaptein, E. M., and Goebelsmann, U., 1980, Prolactin modulation of dehydroepiandrosterone sulfate secretion, Am. J. Obstet. Gynecol. 138: 632–636.PubMedGoogle Scholar
  31. 31.
    Rubin, R. T., Poland, R. E., Sobel, I., Tower, B. B., and Odell, W. D., 1978, Effects of prolactin and prolactin plus luteinizing hormone on plasma testosterone levels in normal adult men, J. Clin. Endocrinol. Metab. 47: 447–456.PubMedCrossRefGoogle Scholar
  32. 32.
    Rubin, R. T., Poland, R. E., Sowers, J. R., and Hershman, J. M., 1978, Influence of methyl-TRH-induced prolactin increase on serum testosterone levels in normal adult men, J. Clin. Endocrinol. Metab. 46: 830–833.PubMedCrossRefGoogle Scholar
  33. 33.
    Pontiroli, A. E., and Pozza, G., 1978, Histamine stimulates prolactin release in normal men, Acta Endocrinol. (Copenhagen) 88: 23–28.Google Scholar
  34. 34.
    Carlson, H. E., and Ippoliti, A. F., 1977, Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man, J. Clin. Endocrinol. Metab. 45: 367–370.PubMedCrossRefGoogle Scholar
  35. 35.
    Pontiroli, A. E., Pellicciotta, G., Alberetto, M., DePasqua, A., Girardi, A. M., and Pozza, G., 1979, Cimetidine and L-dopa in the control of prolactin secretion in man, Norm. Metab. Res. 11: 257–258.CrossRefGoogle Scholar
  36. 36.
    Golstein, J., Vanhaelst, L., Bruno, O. D., and L’Hermite, M., 1979, Effect of cyproheptadine on thyrotrophin and prolactin secretion in normal man, Acta Endocrinol. (Copenhagen) 92: 205–213.Google Scholar
  37. 37.
    Masala, A., Delitala, G., Devilla, L., Alagna, S., and Rovasio, P. P., 1979, Enhancement of insulin-induced prolactin secretion by fluoxetine in man, J. Clin. Endocrinol. Metab. 49: 350–352.PubMedCrossRefGoogle Scholar
  38. 38.
    Foley, K. M., Kourides, I. A., Inturrisi, C. E., Kalko, R. F., Zaroulis, C. G., Posner, J. B., Houde, R. W., and Li, C. H., 1979, Beta endorphin analgesic and hormonal effects in humans, Proc. Natl. Acad. Sci. USA 76: 5377–5381.PubMedCrossRefGoogle Scholar
  39. 39.
    Schulz, S. C., Wagner, R., Van Kammen, D. P., Rogol, A. D., Davies, G. C., Wyatt, R.J., Pickar, D., Bunney, W. E., Jr., and Li, C. H., 1980, Prolactin response in beta-endorphin in man, Life Sci. 27: 1735–1742.PubMedCrossRefGoogle Scholar
  40. 40.
    Tamminga, C. A., Neophytides, A., Chase, T. N., and Frohman, L. A., 1978, Stimulation of prolactin and growth hormone secretion by muscimol, a y-aminobutyric acid agonist, J. Clin. Endocrinol. Metab. 47: 1349–1351.CrossRefGoogle Scholar
  41. 41.
    Isaac, R., Merceron, R. E., Caillens, G., Raymond, J-P., and Ardaillou, R., 1978, Effect of parathyroid hormone on plasma prolactin in man, J. Clin. Endocrinol. Metab. 47: 18–23.CrossRefGoogle Scholar
  42. 42.
    Pontiroli, A. E., Gala, R. R., Pellicciotta, G., DePasqua, A., Girardi, A. M., and Pozza, G., 1979, Study on the reproducibility of human prolactin response to sulpiride, benserazide, insulin hypoglycaemia and arginine infusion Acta Endocrinol (Copenhagen) 91: 410–420.Google Scholar
  43. 43.
    L’Hermite, M., Denayer, P., Golstein, J., Virasoro, E., Vanhaelst, L., Copinschi, G., and Robyn, C., 1978, Acute endocrine profile of sulpiride in the human, Clin. Endocrinol. 9: 195–204.CrossRefGoogle Scholar
  44. 44.
    Healy, D. L., and Burger, H. G., 1978, Sustained elevation of serum prolactin by metoclopramide: A clinical model of idiopathic hyperprolactinemia, J. Clin. Endocrinol. Metab. 46: 709–714.PubMedCrossRefGoogle Scholar
  45. 45.
    Annegers, J. F., Coulam, C. B., Abboud, C. F., Laws, E. R., Jr., and Kurland, L. T., 1978, Pituitary adenoma in Olmsted County, Minnesota, 1935–1977: A report of increasing incidence of diagnosis in women of childbearing age, Mayo Clin. Proc. 53: 641–643.PubMedGoogle Scholar
  46. 46.
    Sherman, B. M., Harris, C. E., Schlechte, J., Duello, T. M., Halmi, N. S., Van Gilder, J., Chappler, F. K., and Granner, D. K., 1978, Pathogenesis of prolactin-secreting pituitary adenomas, Lancet 2: 1019–1021.PubMedCrossRefGoogle Scholar
  47. 47.
    Shy, K. K., McTiernan, A. M., Daling, J. R., and Weiss, N. S., 1983, Oral contraceptive use and the occurrence of pituitary prolactinoma, J. Am. Med. Assoc. 249: 2204–2207.CrossRefGoogle Scholar
  48. 48.
    Carlson, H. E., Levine, G. A., Goldberg, N. J., and Hershman, J. M., 1978, Hyperprolactinemia in multiple endocrine adenomatosis, type I, Arch. Intern. Med. 138: 1807–1808.PubMedCrossRefGoogle Scholar
  49. 49.
    Prosser, P. R., Karam, J. H., Townsend, J. J., and Forsham, P. H., 1979, Prolactin-secreting pituitary adenomas in multiple endocrine adenomatosis, type-1, Ann. Intern. Med. 91: 41–43.PubMedGoogle Scholar
  50. 50.
    Reschini, E., Ferrari, C., Peracchi, M., Fadini, R., Meschia, M., and Crosignani, P., 1980, Effect of dopamine infusion on serum prolactin concentration in normal and hyperprolactinaemic subjects, Clin. Endocrinol. 13: 519–524.CrossRefGoogle Scholar
  51. 51.
    Bansal, S., Lee, L. A., and Woolf, P. D., 1981, Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients, Am. J. Med. 71: 961–966.PubMedCrossRefGoogle Scholar
  52. 52.
    Serri, O., Kuchel, O., Bun, N. T., and Somma, N., 1983, Differential effects of a low dose dopamine infusion on prolactin secretion in normal and hyperprolactinemic subjects, J. Clin. Endocrinol. Metab. 56: 255–259.PubMedCrossRefGoogle Scholar
  53. 53.
    Webb, C. B., Thominet, J. L., Barowsky, H., Berelowitz, M., and Frohman, L. A., 1983, Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia, J. Clin. Endocrinol. Metab. 56: 1089–1093.PubMedCrossRefGoogle Scholar
  54. 54.
    Tucker, H. S. G., Lankford, H. V., Gardner, D. F., and Blackard, W. G., 1980, Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea—amenorrhea syndrome, J. Clin. Endocrinol. Metab. 51: 968–971.PubMedCrossRefGoogle Scholar
  55. 55.
    Nabarro, J. D. N., 1982, Pituitary prolactinomas, Clin. Endocrinol. 17: 129–156.CrossRefGoogle Scholar
  56. 56.
    Wolf, A. S., Musch, K., and Lauritzen, C., 1979, Hyperprolactinemia in anovulatory women: Incidence and endocrine features,]. Endocrinol. Invest. 2: 5–11.Google Scholar
  57. 57.
    Quigley, M. E., Sheehan, K. L., Casper, R. F., and Yen, S. S. C., 1980, Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma, J. Clin. Endocrinol. Metab. 50: 427–430.PubMedCrossRefGoogle Scholar
  58. 58.
    Klibanski, A., Neer, R. M., Beitins, I. Z., Ridgway, E. C., Zervas, N. T., and McArthur, J. W., 1980, Decreased bone density in hyperprolactinemic women, N. Engl. J. Med. 303: 1511–1514.PubMedCrossRefGoogle Scholar
  59. 59.
    Landgraf, R., Landgraf-Leurs, M. M. C., Weismann, A., Horl, R., Von Warder, K., and Scriba, P. C., 1977, Prolactin: A diabetogenic hormone, Diabetologia 13: 99–104.PubMedCrossRefGoogle Scholar
  60. 60.
    Johnston, D. G., Alberti, K. G. M. M., Nattrass, M., Burrin, J. M., Blesamalpica, G., Hall, K., and Hall, R., 1980, Hyperinsulinaemia in hyperprolactinamic women, Clin. Endocrinol. 13: 361–368.Google Scholar
  61. 61.
    Fine, S. A., and Frohman, L. A., 1978, Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting tumors, J. Clin. Invest. 61: 973–980.PubMedCrossRefGoogle Scholar
  62. 62.
    Müller, E. E., Genazzani, A. R., and Murru, S., 1978, Nomifensine: Diagnostic test in hyperprolactinemic states, J. Clin. Endocrinol. Metab. 47: 1352–1357.PubMedCrossRefGoogle Scholar
  63. 63.
    Ferrari, C., Crosignani, P. G., Caldara, R., Picciotti, M. C., Malinverni, A., Barattini, B., Rampini, P., and Telloli, P., 1980, Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemia, J. Clin. Endocrinol. Metab. 50: 23–26.PubMedCrossRefGoogle Scholar
  64. 64.
    Moriondo, P., Travaglini, P., Nissim, M., and Faglia, G., 1980, Evaluation of two inhibitory tets (nomifensine and L-dopa carbidopa) for the diagnosis of hyperprolactinaemic states, Clin. Endocrinol. 13: 525–534.CrossRefGoogle Scholar
  65. 65.
    Hagen, C., Lindholm, J., Suenson, E., Riishede, J., Hummer, L., and Jacobsen, H-H., 1979, Relationship between plasma prolactin concentration and pituitary function in patients with a pituitary adenoma, Clin. Endocrinol. 11: 671–679.CrossRefGoogle Scholar
  66. 66.
    Klijn, J. G. M., Lamberts, W. J., De Jong, F. H., Docter, R., Van Dongen, K. J., and Birkenhager, J. C., 1980, The importance of pituitary tumour size in patients with hyperprolactinaemia in relation to hormonal variables and extrasellar extension of tumour, Clin. Endocrinol. 12: 341–355.CrossRefGoogle Scholar
  67. 67.
    Wass, J. A. H., Williams, J., Charlesworth, M., Kingsley, D. P. E., Halliday, A. M., Doniach, I., Rees, L. H., McDonald, W. I., and Besser, G. M., 1982, Bromocriptine in management of large pituitary tumours, Br. Med. J. 284: 1908–1911.CrossRefGoogle Scholar
  68. 68.
    Breidahl, H. D., Topliss, D. J., and Pike, J. W., 1983, Failure of bromocriptine to maintain reduction in size of a macroprolactinoma, Br. Med. J. 287: 451–452.CrossRefGoogle Scholar
  69. 69.
    Dallabonzana, D., Spelta, B., Oppizzi, G., Tonon, C., Luccarelli, G., Chiodini, P. G., and Liuzzi, A., 1983, Reenlargement of macroprolactinomas during bromocriptine treatment report of two cases, J. Endocrinol. Invest. 6: 47–50.PubMedGoogle Scholar
  70. 70.
    Thorner, M. O., Perryman, R. L., Rogol, A. D., Conway, B. P., MacLeod, R. M., Login, I. S., and Morris, J. L., 1981, Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine, J. Clin. Endocrinol. Metab. 53: 480–483.PubMedCrossRefGoogle Scholar
  71. 71.
    Tindall, G. T., Kovacs, K., Horvath, E., and Thorner, M. 0., 1982, Human prolactin-producing adenomas and bromocriptine: A histological immunocytochemical, ultrastructural and morphometric study, J. Clin. Endocrinol. Metab. 55: 1178–1183.PubMedCrossRefGoogle Scholar
  72. 72.
    Eversmann, T., Fahlbusch, R., Rjosk, H. K., and Von Werder, K., 1979, Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas, Acta Endocrinol. (Copenhagen) 92: 413–427.Google Scholar
  73. 73.
    Aronoff, S. L., Daughaday, W. H., and Laws, E. R., Jr., 1979, Bromocriptine treatment of prolactinomas, N. Engl. J. Med. 300: 1391–1392.PubMedCrossRefGoogle Scholar
  74. 74.
    Wilson, J. D., Newcombe, R. L. G., and Long, F. L., 1983, Cerebrospinal fluid rhinorrhoea during treatment of pituitary tumours with bromocriptine, Acta Endocrinol. (Copenhagen) 103: 457–460.Google Scholar
  75. 75.
    Zarate, A., Canales, E. S., Cano, C., and Pilonieta, C. J., 1983, Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine, Acta Endocrinol. (Copenhagen) 104: 139–142.Google Scholar
  76. 76.
    Thorner, M. O., Edwards, C. R. W., Charlesworth, M., Dacie, J. E., Moult, P. J. A., Rees, L. H., Jones, A. E., and Besser, G. M., 1979, Pregnancy in patients presenting with hyperprolactinaemia, Br. Med. J. 2: 1771–1774.CrossRefGoogle Scholar
  77. 77.
    Bergh, T., Nillius, S. J., Larsson, S.-G., and Wide, L., 1981, Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours, Acta Endocrinol. (Copenhagen) 98: 333–338.Google Scholar
  78. 78.
    Konopka, P., Raymond, J. P., Merceron, R. E., and Seneze, J., 1983, Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas, Am. J. Obstet. Gynecol. 146: 935–937.PubMedGoogle Scholar
  79. 79.
    Franks, S., Horrocks, P. M., Lynch, S. S., Butt, W. R., and London, D. R., 1983, Effectiveness of pergolide mesylate in long term treatment of hyperprolactinaemia, Br. Med. J. 286: 1177–1178.CrossRefGoogle Scholar
  80. 80.
    Landolt, A. M., 1981, Surgical treatment of pituitary prolactinomas: Postoperative prolactin and fertility in seventy patients, Fertil. Steril. 35: 620–625.PubMedGoogle Scholar
  81. 81.
    Randall, R. V., Laws, E. R., Jr., Abboud, C. F., Ebersold, M. J., Kao, P. C., and Scheithauer, B. W., 1983, Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: Results in 100 patients, Mayo Clin. Proc. 58: 108–121.PubMedGoogle Scholar
  82. 82.
    Serri, 0., Rasio, E., Beauregard, H., Hardy, J., and Somma, M., 1983, Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma, N. Engl. J. Med. 309: 280–283.CrossRefGoogle Scholar
  83. 83.
    Miller, W. L., and Eberhardt, N. L., 1983, Structure and evolution of the growth hormone gene family, Endocrine Rev. 4: 97–130.CrossRefGoogle Scholar
  84. 84.
    Martial, J. A., Hallewell, R. A., Baxter, J. D., and Goodman, H. M., 1979, Human growth hormone: Complementary DNA cloning and expression in bacteria, Science 205: 602–606.PubMedCrossRefGoogle Scholar
  85. 85.
    Miozzari, G. F., 1981, Strategies for obtaining expression of peptide hormones in E. coli, in: Insulins, Growth Hormone and Recombinant DNA Technology ( J. L. Gueriguian, ed.), pp. 13–31, Raven Press, New York.Google Scholar
  86. 86.
    Rosenfeld, R. G., Wilson, D. M., and Hintz, R. L., 1982, Biological activity of recombinant DNA-derived human growth hormone in humans: In vitro and in vivo studies, in: Hormone Drugs, Proceedings of the FDA-USP Workshop on Drug and Reference Standards for Insulins, Somatotropins and Thyroid-axis hormones, United States Pharmacopeia] Convention, Inc., Rockville, Md., pp. 352–362.Google Scholar
  87. 87.
    Wallis, M., 1980, Growth hormone: Deletions in the protein and introns in the gene, Nature (London) 284: 512.CrossRefGoogle Scholar
  88. 88.
    Owerbach, D., Rutter, W. J., Martial, J. A., Baxter, J. D., and Shows, T. B., 1980, Genes for growth hormone, chorionic somatomammotropin, and growth hormone-like gene on chromosome 17 in humans, Science 209: 289–292.PubMedCrossRefGoogle Scholar
  89. 89.
    Wallis, M., 1981, The molecular evolution of pituitary growth hormone, prolactin and placental lactogen: A protein family showing variable rates of evolution, J. Mol. Evol. 17: 10–18.CrossRefGoogle Scholar
  90. 90.
    Lewis, U. J., Singh, R. N. P., Tutwiler, G. F., Sigel, M. B., Vanderlaan, E. F., and Vanderlaan, W. P., 1980, Human growth hormone—A complex of proteins, Recent Frog. Horm. Res. 36: 477–508.Google Scholar
  91. 91.
    Eastman, R. C., Lesniak, M. A., Roth, J., Demeyts, P., and Gorden, P., 1979, Regulation of receptor by homologous hormone enhances sensitivity and broadens scope of radioreceptor assay for human growth hormone, J. Clin. Endocrinol. Metab. 49: 262–268.PubMedCrossRefGoogle Scholar
  92. 92.
    Rosenfeld, R. G., and Hintz, R. L., 1980, Modulation of homologous receptor concentrations—Sensitive radioassay for human growth hormone in acromegalic, newborn, and stimulated plasma, J. Clin. Endocrinol. Metab. 50: 62–69.PubMedCrossRefGoogle Scholar
  93. 93.
    Gavin, J. R., Trivedi, B., and Daughaday, W. H., 1979, Homologous radioreceptor and receptor modulation assays for human serum growth hormone: A screening method for growth hormone in serum, Clin. Res. 27: 655A.Google Scholar
  94. 94.
    Tannenbaum, G. S., Epelbaum, J., Colle, E., Brazeau, P., and Martin, J. B., 1978, Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion, Endocrinology 102: 1909–1914.PubMedCrossRefGoogle Scholar
  95. 95.
    Patel, Y. C., 1979, Growth hormone stimulates hypothalamic somatostatin, Life Sci. 24: 1589–1594.PubMedCrossRefGoogle Scholar
  96. 96.
    Tannenbaum, G. S., 1980, Evidence for autoregulation of growth hormone secretion via the central nervous system, Endocrinology 107: 2117–2120.PubMedCrossRefGoogle Scholar
  97. 97.
    Sheppard, M. C., Kronheim, S., and Pimstone, B. L., 1978, Stimulation by growth hormone of somatostatin release from the rat hypothalamus in vitro, Clin. Endocrinol. 9: 583–586.CrossRefGoogle Scholar
  98. 98.
    Berelowitz, M., Firestone, S. L., and Frohman, L. A., 1981, Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution, Endocrinology 109: 714–719.PubMedCrossRefGoogle Scholar
  99. 99.
    Sheppard, M., Pimstone, B., Hendricks, S., Kronheim, S., and Shapiro, B., 1979, Somatomedin A effect on somatostatin release from rat hypothalamus and growth hormone release from perifused pituitary, in: Molecular Endocrinology ( I. Macintyre and M. Szelke, eds.), pp. 141–144, Elsevier/ North-Holland, Amsterdam.Google Scholar
  100. 100.
    Berelowitz, M., Szabo, M., Frohman, L. A., Firestone, S., and Chu, L., 1981, Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary, Science 212: 1279–1281.PubMedCrossRefGoogle Scholar
  101. 101.
    Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., and Wehrenberg, W. B., 1982, Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly, Science 218: 585–587.PubMedCrossRefGoogle Scholar
  102. 102.
    Spiess, J., Rivier, J., Thorner, M., and Vale, W., 1982, Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor, Biochemistry 21: 6037–6040.PubMedCrossRefGoogle Scholar
  103. 103.
    Mayo, K. E., Vale, W., Rivier, J., Rosenfeld, M. G., and Evans, R. M., 1983, Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor, Nature (London) 306: 86–88.CrossRefGoogle Scholar
  104. 104.
    Bloch, B., Brazeau, P., Ling, N., Bohlen, P., Esch, F., Wehrenberg, W. B., Benoit, R., Bloom, F., and Guillemin, R., 1983, Immunohistochemical detection of growth hormone-releasing factor in brain, Nature (London) 301: 607.CrossRefGoogle Scholar
  105. 105.
    Gelato, M. C., Pescovitz, O., Cassorla, F., Loriaux, D. L., and Merriam, G. R., 1983, Effects of a growth hormone releasing factor in man, J. Clin. Endocrinol. Metab. 57: 674–676.PubMedCrossRefGoogle Scholar
  106. 106.
    Rosenthal, S. M., Schriock, E. A., Kaplan, S. L., Guillemin, R., and Grumbach, M. M., Synthetic human pancreas growth hormone-releasing factor (hpGRF),..44-NH2) stimulates growth hormone secretion in normal men, J. Clin. Endocrinol. Metab. 57: 677–679.Google Scholar
  107. 107.
    Pieters, G. F. F. M., Smals, A. G. H., and Kloppenborg, P. W. C., 1980, Defective suppression of growth hormone after oral glucose loading in adolescence, J. Clin. Endocrinol. Metab. 51: 265–270.PubMedCrossRefGoogle Scholar
  108. 108.
    Copinschi, G., DeLaet, M.-H., Brion, J. P., Leclercq, R., L’Hermite, M., Robyn, C., Virasoro, E., and Van Cauter, E., 1978, Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects: Influence of prolonged fasting in obesity, Clin. Endocrinol. 9: 15–26.CrossRefGoogle Scholar
  109. 108a.
    Hayford, J. T., Danney, M. M., Hendrix, J. A., and Thompson, R. G., 1979, Integrated concentration of growth hormone in juvenile-onset diabetes, Diabetes 29: 391–398.CrossRefGoogle Scholar
  110. 109.
    Clark, R. W., Schmidt, H. S., and Malarkey, W. B., 1979, Disordered growth hormone and prolactin secretion in primary disorders of sleep, Neurology 29: 855–861.PubMedCrossRefGoogle Scholar
  111. 110.
    Golde, D. W., Bersch, N., and Li, C. H., 1978, Growth hormone modulation of murine erythroleukemia cell growth in vitro, Proc. Natl. Acad. Sci. USA 75: 3437–3439.PubMedCrossRefGoogle Scholar
  112. 111.
    Gauwerky, C., Golde, D. W., and Li, C. H., 1980, Growth hormone polypeptides stimulate proliferation of K562 human erythroleukemia cells, J. Clin. Endocrinol. Metab. 51: 1208–1210.PubMedCrossRefGoogle Scholar
  113. 112.
    Isaksson, O. G. P., Jansson, J.-O., and Gause, I. A. M., 1982, Growth hormone stimulates longitudinal bone growth directly, Science 216: 1237–1238.PubMedCrossRefGoogle Scholar
  114. 113.
    Eden, S., Isaksson, O. G. P., Madsen, K., and Friberg, U., 1983, Specific binding of growth hormone to isolated chondrocytes from rabbit ear and epiphyseal plate, Endocrinology 112: 1127–1129.PubMedCrossRefGoogle Scholar
  115. 114.
    Spanos, E., Barrett, D., Maclntyre, I., Pike, J. W., Safilian, E. F., and Haussier, M. R., 1978, Effect of growth hormone on vitamin D metabolism, Nature (London) 273: 246–247.CrossRefGoogle Scholar
  116. 115.
    Yeh, J. K., and Aloia, J. F., 1979, The influence of growth hormone on vitamin D metabolism, Biochem. Med. 21: 311–322.PubMedCrossRefGoogle Scholar
  117. 116.
    Bruns, M. E. H., Vollmer, S. S., Bruns, D. E., and Overpeck, J. G., 1983, Human growth hormone increases intestinal vitamin D-dependent calcium-binding protein in hypophysectomized rats, Endocrinology 113: 1387–1392.PubMedCrossRefGoogle Scholar
  118. 117.
    Gertner, J. M., Horst, R. L., Broadus, A. E., Rasmussen, H., and Genel, M., 1979, Parathyroid function and vitamin-D metabolism during human growth hormone replacement, J. Clin. Endocrinol. Metab. 49: 185–188.PubMedCrossRefGoogle Scholar
  119. 118.
    Chipman, I. J., Zerwekh, J., Nicar, M., and Marks, J., 1980, Effect of growth hormone administration-Reciprocal changes in serum 1-alpha, 25-dihydroxyvitamin D and intestinal calcium absorption, J. Clin. Endocrinol. Metab. 51: 321–324.PubMedCrossRefGoogle Scholar
  120. 119.
    Hammerman, M. R., Karl, I. E., and Hruska, K. A., 1980, Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone, Biochim. Biophys. Acta 603: 322–335.PubMedCrossRefGoogle Scholar
  121. 120.
    Melmed, S., Braunstein, G. D., Horvath, E., Ezrin, C., and Kovacs, K., 1983, Pathophysiology of acromegaly, Endocrine Rev. 4: 271–290.CrossRefGoogle Scholar
  122. 121.
    Thorner, M. O., Perryman, R. L., Cronin, M. J., Rogol, A. D., Draznin, M., Johanson, A., Vale, W., Horvath, E., and Kovacs, K., 1982, Somatotroph hyperplasia: Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor, J. Clin. Invest. 70: 965–977.PubMedCrossRefGoogle Scholar
  123. 122.
    Leveston, S. A., McKeel, D. W., Jr., Buckley, P. J., Deschryver, K., Greider, M. H., Jaffe, B. M., and Daughaday, W. H., 1981, Acromegaly and Cushing’s syndrome associated with a foregut carcinoid tumor, J. Clin. Endocrinol. Metab. 53: 682–689.PubMedCrossRefGoogle Scholar
  124. 123.
    Asa, S. L., Bilbao, J. M., Kovacs, K., and Linfoot, J. A., 1980, Hypothalamic neuronal hamartoma associated with pituitary growth hormone cell adenoma and acromegaly, Acta Neuropathol. 52: 231–234.PubMedCrossRefGoogle Scholar
  125. 124.
    Hanew, K., Kokubun, M., Sasaki, A., Mouri, T., and Yoshinaga, K., 1980, The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly, J. Clin. Endocrinol. Metab. 51: 292–297.PubMedCrossRefGoogle Scholar
  126. 125.
    Camanni, F., Picotti, G. B., Massara, F., Molinatti, G. M., Mantegazza, P., and Muller, E. E., 1978, Carbidopa inhibits the growth hormone-and prolactin-suppresive effect of L-dopa in acromegalic patients, J. Clin. Endocrinol. Metab. 47: 647–652.PubMedCrossRefGoogle Scholar
  127. 126.
    Harrison, B. D. W., Millhouse, K. A., Harrington, M., and Nabarro, J. D. N., 1978, Lung function in acromegaly, Q. J. Med. 47: 517–532.PubMedGoogle Scholar
  128. 127.
    Luboshitzky, R., and Barzilai, D., 1980, Hypoxemia and pulmonary function in acromegaly, Am. Rev. Respir. Dis. 121: 471–476.PubMedGoogle Scholar
  129. 128.
    Perks, W. H., Horrocks, P. M., Cooper, R. A., Bradbury, S., Allen, A., Baldock, N., Prowse, K., and Van’t Hoff, W., 1980, Sleep apnoea in acromegaly, Br. Med. J. 280: 894–896.PubMedCrossRefGoogle Scholar
  130. 129.
    Cadieux, R. J., Kales, A., Santen, R. J., Bixler, E. O., and Gordon, R., 1982, Endoscopic findings in sleep apnea associated with acromegaly, J. Clin. Endocrinol. Metab. 55: 18–22.PubMedCrossRefGoogle Scholar
  131. 130.
    Lie, J. T., and Grossman, S.J., 1980, Pathology of the heart in acromegalyAnatomic findings in 27 autopsied patients, Am. Heart Jr. 100: 41–52.CrossRefGoogle Scholar
  132. 131.
    Smallridge, R. C., Rajfer, S., Davia, J., and Schaaf, M., 1979, Acromegaly and the heart: An echocardiographic study, Am. J. Med. 66: 22–27.PubMedCrossRefGoogle Scholar
  133. 132.
    Savage, D. D., Henry, W. L., Eastman, R. C., Borer, J. S., and Gorden, P., 1979, Echocardiographic assessment of cardiac anatomy and function in acromegalic patients, Am. J. Med. 67: 823–829.PubMedCrossRefGoogle Scholar
  134. 133.
    Ondreyco, S. M., Lewis, H. D., and Hartman, C. R., 1980, Myxomatous degeneration and cystic medial necrosis associated with acromegaly, Arch. Intern. Med. 140: 547–549.PubMedCrossRefGoogle Scholar
  135. 134.
    Mantero, F., Opocher, G., Armanini, D., Paviotti; G., Boscaro, M., and Muggeo, M., 1979, Plasma renin activity and urinary aldosterone in acromegaly, J. Endocrinol. Invest. 2: 13–18.Google Scholar
  136. 135.
    Ogihara, T., Hata, T., Maruyama, A., Mikami, H., Nakamaru, M., Okada, Y., and Kumahara, Y., 1979, Blood pressure response to an angiotensin II antagonist in patients with acromegaly, J. Clin. Endocrinol. Metab. 48: 159–162.PubMedCrossRefGoogle Scholar
  137. 136.
    Moore, T. J., Theinwai, W., Dluhy, R. G., Dawson-Hughes, B. F., Hollenberg, N. K., and Williams, G. H., 1980, Abnormal adrenal and vascular response to angiotensin-II and an angiotensin antagonist in acromegaly, J. Clin. Endocrinol. Metab. 51: 215–222.PubMedCrossRefGoogle Scholar
  138. 137.
    Whitehead, E. M., Shalet, S. M., Davies, D., Enoch, B. A., Price, D. A., and Beardwell, C. G., 1982, Pituitary gigantism: A disabling condition, Clin. Endocrinol. 17: 271–278.CrossRefGoogle Scholar
  139. 138.
    Daughaday, W. H., 1977, Extreme gigantism, N. Engl. J. Med. 297: 1267–1269.PubMedCrossRefGoogle Scholar
  140. 139.
    Wass, J. A. H., Cudworth, A. G., Bottazzo, G. F., Woodrow, J. C., and Besser, G. M., 1980, An assessment of glucose intolerance in acromegaly and its response to medical treatment, Clin. Endocrinol. 12: 53–60.CrossRefGoogle Scholar
  141. 140.
    Maneschi, F., Navalesi, R., Pilo, A., and Paci, A., 1978, [1251] hGH metabolism in acromegaly: Effects of chronic treatment with 2-Br-a-ergocryptine, J. Clin. Endocriol. Metab. 47: 110–118.Google Scholar
  142. 141.
    Muggeo, M., Bar, R. S., Roth, J., Kahn, C. R., and Gorden, P., 1979, The insulin resistance of acromegaly: Evidence for two alterations in the insulin receptor on circulating monocytes, J. Clin. Endocrinol. Metab. 48: 17–25.PubMedCrossRefGoogle Scholar
  143. 142.
    Hardy, J., and Somma, M., 1979, Acromegaly: Surgical treatment by trans-sphenoidal microsurgical removal of the pituitary adenoma, in: Clinical Management of Pituitary Tumors ( G. T. Tindall and W. F. Collins, eds.), pp. 209–217, Raven Press, New York.Google Scholar
  144. 143.
    Laws, E. R., Jr., Piepgras, D. G., Randall, R. V., and Abboud, C. F., 1979, Neurosurgical management of acromegaly: Results in 82 patients treated betwen 1972 and 1977, J. Neurosurg. 50: 454–461.PubMedCrossRefGoogle Scholar
  145. 144.
    Tucker, H. S. G., Grubb, S. R. Wigand, J. P., Watlington, C. O., Blackard, W. G., and Becker, D. P., 1980, The treatment of acromegaly by trans-sphenoidal surgery, Arch. Intern. Med. 140: 795–803.PubMedCrossRefGoogle Scholar
  146. 145.
    Clemmons, D. R., Van Wyk, J. J., Ridgway, E. C., Kliman, B., Kjellberg, R. N., and Underwood, L. E., 1979, Evaluation of acromegaly by radioimmunoassay of somatomedin-C, N. Engl. J. Med. 301: 1138–1142.PubMedCrossRefGoogle Scholar
  147. 146.
    Faglia, G., Paracchi, A., Ferrari, C., and Beck-Peccoz, P., 1978, Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone, Clin. Endocrinol. 8: 373–380.CrossRefGoogle Scholar
  148. 147.
    Wass, J. A. H., Thorner, M. O., Morris, D. V., Rees, L. H., Mason, A. S., Jones, A. E., and Besser, G. M., 1977, Long-term treatment of acromegaly with bromocriptine, Br. Med. J. 2: 875–878.CrossRefGoogle Scholar
  149. 148.
    Shalet, S. M., Price, D. A., Beardwell, C. G., Mindel, A., and MacFarlane, I. A., 1980, Growth hormone and somatomedin levels in acromegalics treated with bromocriptine, Horm. Res. 12: 121–129.PubMedCrossRefGoogle Scholar
  150. 149.
    Lindholm, J., Rushede, J., Vestergaard, S., Hummer, L., Faber, O., and Hagen, C., 1981, No effect of bromocriptine in acromegaly, N. Engl. J. Med. 304: 1450–1454.PubMedCrossRefGoogle Scholar
  151. 150.
    Pelkonen, R., Ylikahri, R., and Karonen, S-L., 1980, Bromocriptine treatment of patients with acromegaly resistant to conventional therapy, Clin. Endocrinol. 12: 219–224.CrossRefGoogle Scholar
  152. 151.
    Eastman, R. C., Gorden, P., and Roth, J., 1979, Conventional supervoltage irradiation is an effective treatment for acromegaly, J. Clin. Endocrinol. Metab. 48: 931–940.PubMedCrossRefGoogle Scholar
  153. 152.
    Atkinson, A. B., Allen, I. V., Gordon, D. S., Hadden, D. R., Maguire, C. J. F., Trimble, E. R., and Lyons, A. R., 1979, Progressive visual failure in acromegaly following external pituitary irradiation, Clin. Endocrinol. 10: 469–480.CrossRefGoogle Scholar
  154. 153.
    Veldhuis, J. D., and Hammond, J. M., 1980, Endocrine function after spontaneous infarction of the human pituitary: Report, review, and reappraisal, Endocr Rev. 1: 100–107.PubMedCrossRefGoogle Scholar
  155. 154.
    Jordon, R. M., Cook, D. M. McDonald, W.J. Houghton, D. C., and Kendall, J. W., 1980, Corticotrophin, growth hormone and prolactin deficiencies with hypoaldosterone and corticosteroid-reversible hypothyroidism in Sheehan’s syndrome—Clinical and anatomical correlations, Acta Endocrinol. (Copenhagen) 95: 12–22.Google Scholar
  156. 155.
    Rothman, J. G., Snyder, P. J., and Utiger, R. D., 1978, Hypothalamic endocrinopathy in Hand-Schuller-Christian disease, Ann. Intern. Med. 88: 512–513.PubMedGoogle Scholar
  157. 156.
    Jambart, S., Turpin, G., and de Gennes, J. L., 1980, Panhypopituitarism secondary to head trauma: Evidence for a hypothalamic origin of the deficit, Acta Endocrinol. (Copenhagen) 93: 264–270.Google Scholar
  158. 157.
    Stuart, C. A., Neelon, F. A., and Lebovitz, H. E., 1978, Hypothalamic insufficiency the cause of’ hypopituitarism in sarcoidosis, Ann. Intern. Med. 88: 589–594.PubMedGoogle Scholar
  159. 158.
    Hendricks, S. A., Lippe, B. M., Kaplan, S. A., and Bentson, J. R., 1981, Hypothalamic atrophy with progressive hypopituitarism in an adolescent girl, J. Clin. Endocrinol. Metab. 52: 563–564.Google Scholar
  160. 159.
    Kupari, M., Pelkonen, R., and Valtonen, V., 1980, Post-encephalitic hypothalamic–pituitary insufficiency, Acta Endocrinol. (Copenhagen) 94: 433–438.Google Scholar
  161. 160.
    Krause-Brucker, W., and Gardner, D. W., 1980, Optic nerve hypoplasia associated with absent septum pellucidum and hypopituitarism, Am. J. Ophthalmol. 89: 113–120.PubMedGoogle Scholar
  162. 161.
    Rudman, D., Davis, G. T., Priest, J. H., Patterson, J. H., Kutner, M. H., Heymsfield, S. B., and Bethel, R. A., 1978, Prevalence of growth hormone deficiency in children with cleft lip or palate, J. Pediatr. 93: 378–382.PubMedCrossRefGoogle Scholar
  163. 162.
    Parks, J. S., Tenore, A., Bongiovanni, A. M., and Kirkland, R. T., 1978, Familial hypopituitarism with large sella turcica, N. Engl. J. Med. 298: 698–702.PubMedCrossRefGoogle Scholar
  164. 163.
    Rona, R. J., and Tanner, J. M., 1977, Aetiology of idiopathic growth hormone deficiency in England and Wales, Arch. Dis. Child. 52: 1197–1208.CrossRefGoogle Scholar
  165. 164.
    Steendijk, R., 1980, Diagnostic and aetiologic features of idiopathic and symptomatic growth hormone deficiency in the Netherlands—A survey of 176 children, Heiv. Paediatr. Acta 35: 129–139.Google Scholar
  166. 165.
    Calzada, L.-D., Chaussain, J.-L., and Job, J.-C., 1978, Etiologie et associations du nanisme hypophysaire, Arch. Fr. Pediatr. 35: 144–150.PubMedGoogle Scholar
  167. 166.
    Illig, R., 1970, Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH), J. Clin. Endocrinol. Metab. 31: 679–692.PubMedCrossRefGoogle Scholar
  168. 167.
    Phillips, J. A., Hjelle, B. L., Seeburg, P. H., and Zachmann, M., 1981, Molecular basis for familial isolated growth hormone deficiency, Proc. Natl. Acad. Sci. USA 78: 6372–6375.PubMedCrossRefGoogle Scholar
  169. 168.
    Phillips, J. A., III, Parks, J. S., Hjelle, B. L., Herd, J. E., Plotnick, L. P., Migeon, C. J., and Seeburg, P. H., 1982, Genetic analysis of familial isolated growth hormone deficiency type I, J. Clin. Invest. 70: 489–495.PubMedCrossRefGoogle Scholar
  170. 169.
    Plotnick, L. P., Lee, P. A., Migeon, C. J., and Kowarski, A. A., 1979, Comparison of physiological and pharmacological tests of growth hormone function in children with short stature, J. Clin. Endocrinol. Metab. 48: 811–815.PubMedCrossRefGoogle Scholar
  171. 170.
    Fass, B., Lippe, B. M., and Kaplan, S. A., 1979, Relative usefulness of 3 growth hormone stimulation screening tests, Am. J. Dis. Child. 133: 931–933.PubMedGoogle Scholar
  172. 171.
    Gil-Ad, I., Topper, E., and Laron, Z., 1979, Oral clonidine as a growth hormone stimulation test, Lancet 2: 278–279.PubMedCrossRefGoogle Scholar
  173. 172.
    Ferrari, C., Caldara, R., Testori, G. P., Crossignani, R., and Barbieri, C., 1979, Clonidine and growth-hormone secretion, Lancet 2: 796.PubMedCrossRefGoogle Scholar
  174. 173.
    Spiliotis, B. E., August, G. P., Hung, W., Sonis, W., Meldelson, W., and Bercu, B. B., 1984, Growth hormone neurosecretory dysfunction, J. Am. Med. Assoc. 251: 2223–2230.CrossRefGoogle Scholar
  175. 174.
    Demura, R., Yamaguchi, H., Wakabayashi, I., Demura, H., and Shizume, K., 1980, The effect of hGH on hypothalamic–pituitary–thyroid function in patients with pituitary dwarfism, Acta Endocrinol (Copenhagen) 93: 13–19.Google Scholar
  176. 175.
    Milner, R. D. G., Fraser, T. R., Brook, C. G. D., Cotes, P. M., Farquhar, J. W., Parkin, J. M., Preece, M. A., Snodgrass, G. J. A. I., Mason, A. S., Tanner, J. M., and Vince, F. P., 1979, Experience with human growth hormone in Great Britain: The report of the MRC working party, Clin. Endocrinol. 11: 15–38.CrossRefGoogle Scholar
  177. 176.
    Kirkland, R. T., and Clayton, G. W., 1979, Growth increments with low dose intermittent growth hormone and fluoxymesterone in 1st year of therapy in hypopituitarism, Pediatrics 63: 386–388.PubMedGoogle Scholar
  178. 177.
    Rosenbloom, A. L., Riley, W. J., Silverstein, J. H., Garnica, A. D., Netzloff, M. L., and Weber, F. T., 1980, Low dose single weekly injections of growth hormone—Response during 1st year of therapy of hypopituitarism, Pediatrics 66: 272–276.PubMedGoogle Scholar
  179. 178.
    Golde, D. W., Bersch, N., Kaplan, S. A., Rimoin, D. L., and Li, C. H., 1980, Peripheral unresponsiveness to human growth hormone in Laron dwarfism, N. Engl. J. Med. 303: 1156–1159.PubMedCrossRefGoogle Scholar
  180. 179.
    Eshet, R., Laron, Z., Pertzelan, A., Arnon, R., and Dintzman, M., 1984, Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism, Isr. J. Med. Sci. 20: 8–11.Google Scholar
  181. 180.
    Rinderknecht, E., and Humbel, R. E., 1978, The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin, J. Biol. Chem. 253: 2769–2776.PubMedGoogle Scholar
  182. 181.
    Rinderknecht, E., and Humbel, R. E., 1978, Primary structure of human insulin-like growth factor II, FEBS Lett. 89: 283–286.PubMedCrossRefGoogle Scholar
  183. 182.
    Klapper, D. G., Svoboda, M. E., and Van Wyk, J. J., 1983, Sequence analysis of somatomedin-C: Confirmation of identity with insulin-like growth factor I, Endocrinology 112: 2215–2217.PubMedCrossRefGoogle Scholar
  184. 183.
    Heldin, C.-H., Wasteson, A., Fryklund, L., and Westermark, B., 1981, Somatomedin B: Mitogenic activity derived from contaminant epidermal growth factor, Science 213: 1122–1123.PubMedCrossRefGoogle Scholar
  185. 184.
    Furlanetto, R. W., Underwood, L., Van Wyk, J. J., and D’Ercole, A. J., 1977, Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay, J. Clin. Invest. 60: 648–657.PubMedCrossRefGoogle Scholar
  186. 185.
    Bala, R. M., and Bhaumick, B., 1979, Radioimmunoassay of a basic somatomedin: Comparison of various assay techniques and somatomedin levels in various sera, J. Clin. Endocrinol. Metab. 49: 770–779.PubMedCrossRefGoogle Scholar
  187. 186.
    Clemmons, D. R., Underwood, L. E., Chatelain, P. G., and Van Wyk, J. J., 1983, Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin, J. Clin. Endocrinol. Metab. 56: 384–389.PubMedCrossRefGoogle Scholar
  188. 187.
    Zapf, J., Walter, H., and Froesch, E. R., 1981, Radioimunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia, J. Clin. Invest. 68: 1321–1330.PubMedCrossRefGoogle Scholar
  189. 188.
    Daughaday, W. H., Mariz, I. K., and Blethen, S. L., 1980, Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum, J. Clin. Endocrinol. Metab. 51: 781–788.PubMedCrossRefGoogle Scholar
  190. 189.
    Daughaday, W. H., Mariz, I. K., and Trivedi, B., 1981, A preferential binding site for insulin-like growth factor II in human and rat placental membranes, J. Clin. Endocrinol. Metab. 53: 282–288.PubMedCrossRefGoogle Scholar
  191. 190.
    Daughaday, W. H., Trivedi, B., and Kapadia, M., 1981, Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia, J. Clin. Endocrinol. Metab. 53: 289–294.PubMedCrossRefGoogle Scholar
  192. 191.
    Hintz, R. L., and Liu, R., 1981, Insulin-like growth factor-II radioimmunoassay based on an antiserum against the synthetic C-peptide segment, Clin. Res. 29: 408A.Google Scholar
  193. 192.
    Furlanetto, R. W., 1980, The somatomedin-C binding protein: Evidence for a heterologous subunit structure, J. Clin. Endocrinol. Metab. 51: 12–19.PubMedCrossRefGoogle Scholar
  194. 193.
    White, R. M., Nissley, S. P., Moses, A. C., Rechler, M. M., and Johnsonbaugh, R. E., 1981, The growth hormone dependence of a somatomedinbinding protein in human serum, J. Clin. Endocrinol. 53: 49–57.CrossRefGoogle Scholar
  195. 194.
    Hintz, R. L., Liu, F., Rosenfeld, R. G., and Kemp, S. F., 1981, Plasma somatomedin-binding proteins in hypopituitarism: Changes during growth hormone therapy, J. Clin. Endocrinol. Metab. 53: 100–104.PubMedCrossRefGoogle Scholar
  196. 195.
    Furlanetto, R. W., Underwood, L. E., Van Wyk, J. J., and Handwerger, S., 1978, Serum immunoreactive somatomedin-C is elevated late in pregnancy, J. Clin. Endocrinol. Metab. 47: 695–698.PubMedCrossRefGoogle Scholar
  197. 196.
    Bala, R. M., Lopatka, J., Leung, A., McCoy, E., and McArthur, E., 1981, Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth, J. Clin. Endocrinol. Metab. 52: 508–512.PubMedCrossRefGoogle Scholar
  198. 197.
    Wilson, D. M., Bennett, A., Adamson, G. D., Nagashima, R. J., Liu, F., DeNatale, M. L., Hintz, R. L., and Rosenfeld, R. G., 1982, Somatomedins in pregnancy: A cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies, J. Clin. Endocrinol. Metab. 55: 858–861.PubMedCrossRefGoogle Scholar
  199. 198.
    Hall, K., Enberg, G., Ritzen, M., Svan, H., Fryklund, L., and Takano, K., 1980, Somatomedin-A levels in serum from healthy children and from children with growth hormone deficiency or delayed puberty, Acta Endocrinol. (Copenhagen) 94: 155–165.Google Scholar
  200. 199.
    Rudman, D., Kutner, M. H., Rogers, C. M., Lubin, M. F., Fleming, G. A., and Bain, R. P., 1981, Impaired growth hormone secretion, J. Clin. Invest. 67: 1361–1369.PubMedCrossRefGoogle Scholar
  201. 200.
    Minuto, F., Underwood, L. E., Grimaldi, P., Furlanetto, R. W., Van Wyk, J. J., and Giordano, G., 1981, Decreased serum somatomedin-C concentrations during sleep: Temporal relationship to the nocturnal surges of growth hormone and prolactin, J. Clin. Endocrinol. Metab. 52: 399–403.PubMedCrossRefGoogle Scholar
  202. 201.
    Hintz, R. L., Suskind, R., Amatayakul, K., Leitzmann, C., and Olson, R. E., 1978, Somatomedin and growth hormone in children with protein calorie malnutrition, J. Pediatr. 92: 153–156.PubMedCrossRefGoogle Scholar
  203. 202.
    Clemmons, D. R., Klibanski, A., Underwood, L. E., McArthur, J. W., Ridgway, E. C., Beitins, I. Z., and Van Wyk, J. J., 1981, Reduction of plasma immunoreactive somatomedin C during fasting in humans, J. Clin. Endocrinol. Metab. 53: 1247–1250.PubMedCrossRefGoogle Scholar
  204. 203.
    Isley, W. L., Underwood, L. E., and Clemmons, D. R., 1983, Dietary components that regulate serum somatomedin-C concentrations in humans, Clin. Invest. 71: 175–182.CrossRefGoogle Scholar
  205. 204.
    Rappaport, R., Prevot, C., and Czernichow, P., 1980, Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa, Acta Paediatr. Scand. 69: 37–42.PubMedCrossRefGoogle Scholar
  206. 205.
    Winter, R. J., Phillips, L. S., Green, O. C., and Traisman, H. S., 1980, Somatomedin activity in the Mauriac syndrome, J. Pediatr. 97: 598–600.PubMedCrossRefGoogle Scholar
  207. 206.
    Nash, H., 1979, Growth failure, somatomedin and growth hormone levels in juvenile diabetes mellitus: A pilot study, Aust. N.Z. J. Med. 9: 245–249.PubMedCrossRefGoogle Scholar
  208. 207.
    Winter, R. J., Phillips, L. S., Klein, M. N., Traisman, H. S., and Green, O. C., 1979, Somatomedin activity and diabetic control in children with insulin-dependent diabetes, Diabetes 28: 952–954.PubMedCrossRefGoogle Scholar
  209. 208.
    Tamborlane, W. V., Hintz, R. L., Bergman, M., Genel, M., Felig, P., and Sherwin, R. S., 1981, Insulin-infusion-pump treatment of diabetes, influence of improved metabolic control on plasma somatomedin levels, N. Engl. J. Med. 305: 303–307.PubMedCrossRefGoogle Scholar
  210. 209.
    Blethen, S. L., White, N. H., Santiago, J. V., and Daughaday, W. H., 1981, Plasma somatomedins, endogenous insulin secretion and growth in transient neonatal diabetes mellitus, J. Clin. Endocrinol. Metab. 52: 144–147.PubMedCrossRefGoogle Scholar
  211. 210.
    Phillips, L. S., Pennisi, A. J., Belosky, D. C., Uittenbogaart, C., Ettenger, R. B., Malekzaden, M. H., and Fine, R. N., 1978, Somatomedin activity and inorganic sulfate in children undergoing hemodialysis, J. Clin. Endocrinol. Metab. 46: 165–168.PubMedCrossRefGoogle Scholar
  212. 211.
    Takano, K., Hall, K., Kastrup, K. W., Hizuka, N., Shizume, K., Kawai, K., Akimoto, M., Takuma, T., and Sugino, N., 1979, Serum somatomedin-A in chronic renal failure, J. Clin. Endocrinol. Metab. 48: 371–376.PubMedCrossRefGoogle Scholar
  213. 212.
    Goldberg, A. C., Trivedi, B., Delmez, J. A., Harter, H. R., and Daughaday, W. H., 1981, Uremia reduces serum insulin-like growth factor-I concentration but markedly increases serum insulin-like growth factor-II concentration, Clin. Res. 29: 770A.Google Scholar
  214. 213.
    Schiffrin, A., Guyda, H., Robitaille, P., and Posner, B., 1978, Increased plasma somatomedin reactivity in chronic renal failure as determined by acid gel filtration and radioreceptor assay, J. Clin. Endocrinol. Metab. 46: 511–514.PubMedCrossRefGoogle Scholar
  215. 214.
    Copeland, K. C., Underwood, L. E., and Van Wyk, J. J., 1980, Induction of immunoreactive somatomedin-C in human serum by growth hormone: Dose—response relationships and effect on chromatographic profiles, J. Clin. Endocrinol. Metab. 50: 690–697.PubMedCrossRefGoogle Scholar
  216. 215.
    Kowarski, A. A., Schneider, J., Ben-Galim, E., Weldon, V. V., and Daughaday, W. H., 1978, Growth failure with normal serum RIA-GH and low somatomedin activity: Somatomedin restoration and growth acceleration after exogenous GH, J. Clin. Endocrinol. Metab. 47: 461–464.PubMedCrossRefGoogle Scholar
  217. 216.
    Rudman, D., Kutner, M. H., Goldsmith, M. A., Kenny, J., Jennings, H., and Bain, R. P., 1980, Further observations on four subgroups of normal variant short stature, J. Clin. Endocrinol. Metab. 51: 1378–1384.PubMedCrossRefGoogle Scholar
  218. 217.
    Rudman, D., Kutner, M. H., Blackson, R. D., Cushman, R. A., Bain, R. P., and Patterson, J. H., 1981, Children with normal-variant short stature: Treatment with human growth hormone for six months, N. Engl. J. Med. 305: 123–131.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • William H. Daughaday
    • 1
  1. 1.Metabolism Division, Department of MedicineWashington University School of MedicineSt. LouisUSA

Personalised recommendations